NewYork-Presbyterian’s behavioral health experts provide cutting-edge psychiatric care for a range of conditions and are committed to researching breakthrough treatment options that improve patient outcomes for a growing population of people living with mental health disorders. In 2025, clinicians and researchers from Columbia and Weill Cornell Medicine made significant advancements in identifying new therapeutic targets for anxiety, integrating care for ADHD and concurrent alcohol use disorder, developing AI-based tools to predict schizophrenia risk, and more. These developments are paving the way for advanced treatments and therapies that will benefit more patients.